- Home
- XPEL vs NEO Comparison
XPEL vs NEO Comparison
Compare XPEL & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPEL
- NEO
- Stock Information
- Founded
- XPEL 1999
- NEO 2001
- Country
- XPEL United States
- NEO United States
- Employees
- XPEL N/A
- NEO N/A
- Industry
- XPEL Industrial Specialties
- NEO Precision Instruments
- Sector
- XPEL Industrials
- NEO Health Care
- Exchange
- XPEL Nasdaq
- NEO Nasdaq
- Market Cap
- XPEL 1.2B
- NEO 1.2B
- IPO Year
- XPEL N/A
- NEO 1999
- Fundamental
- Price
- XPEL $44.19
- NEO $11.48
- Analyst Decision
- XPEL
- NEO Buy
- Analyst Count
- XPEL 0
- NEO 10
- Target Price
- XPEL N/A
- NEO $12.56
- AVG Volume (30 Days)
- XPEL 375.1K
- NEO 3.0M
- Earning Date
- XPEL 11-05-2025
- NEO 10-28-2025
- Dividend Yield
- XPEL N/A
- NEO N/A
- EPS Growth
- XPEL N/A
- NEO N/A
- EPS
- XPEL 1.69
- NEO N/A
- Revenue
- XPEL $461,460,000.00
- NEO $709,162,000.00
- Revenue This Year
- XPEL $12.54
- NEO $10.74
- Revenue Next Year
- XPEL $10.52
- NEO $9.85
- P/E Ratio
- XPEL $26.17
- NEO N/A
- Revenue Growth
- XPEL 10.29
- NEO 10.10
- 52 Week Low
- XPEL $24.25
- NEO $4.72
- 52 Week High
- XPEL $47.23
- NEO $19.12
- Technical
- Relative Strength Index (RSI)
- XPEL 77.86
- NEO 68.82
- Support Level
- XPEL $39.61
- NEO $9.89
- Resistance Level
- XPEL $41.20
- NEO $10.44
- Average True Range (ATR)
- XPEL 1.95
- NEO 0.57
- MACD
- XPEL 0.54
- NEO 0.03
- Stochastic Oscillator
- XPEL 94.67
- NEO 97.40
About XPEL XPEL Inc.
XPEL Inc is a supplier of protective films, coatings, and related services to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from the sale of automotive products and related services while the remainder of its revenue is derived from non-automotive products including architectural window film and marine and flat surface protection films. The majority of revenue is derived from the United States.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.